イリノイ州における過体重の臨床試験
イリノイ州内の拠点で、過体重に関する38件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07752979Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Charter Research LLC - Chicago, Chicago
- Flourish Research - Chicago, Chicago
- AMR Clinical - Chicago Oak Brook, Oak Brook
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07685808AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Great Lakes Clinical Trials, Chicago
- Clinical Investigation Spec Gurnee, Gurnee
- Endeavor Health, Skokie
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Chicago Research Center, Inc, Chicago
- Endeavor Health, Skokie
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Christie Clinic, Champaign
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT07837973A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Great Lakes Clinical Trials - Ravenswood, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
- Endeavor Health - Family Medicine Administration, Evanston
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Champaign
- Research Site, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Ann and Robert Lurie Children's Hospital of Chicago, Chicago
- University of Illinois at Chicago, Chicago
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Rush University Medical Center, Chicago
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Rush University Medical Center, Chicago
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Endeavor Health-Northwest Community Healthcare, Arlington Heights
- Eagle Clinical Research, Chicago
- University of Chicago, Chicago
- 他2件
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Great Lakes Clinical Trials - Ravenswood, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NorthShore University Health System, Skokie
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Chicago
- Research Site, Melrose Park
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Schaumburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Schaumburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Elevate Clinical Research, Gurnee
- Knownwell, Schaumburg
- Endeavor Health, Skokie
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- University Of Chicago, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/11更新 · NCT07571005AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Chicago Research Center, Inc, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07571109A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Walgreens - Store 11760, Oak Park
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07745504Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Flourish Research - Great Lakes Clinical Trials, Chicago
- Endeavor Health, Skokie
- Evanston Premier Healthcare Research LLC, Skokie
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Skokie
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901BRIDGE & Friends Trial
- University of Illinois Chicago, Chicago
被験者募集中健康なボランティア歓迎
50歳〜79歳 · 全性別 · 2026/09/01更新 · NCT07798557Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Endeavor Health, Skokie
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/08/27更新 · NCT07575399Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
- Illinois Institute of Technology, Chicago
被験者募集中健康なボランティア歓迎
21歳〜74歳 · 全性別 · 2026/08/27更新 · NCT07566325A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Champaign
- Research Site, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Clinical Investigation Spec Gurnee, Gurnee
- Evanston Premier Hlthcr Res, Skokie
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07509307Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Chicago
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Jesse Brown VA Medical Center, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/07/22更新 · NCT06390345FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
- Mile Square Health Center Chicago, Chicago
- Mile Square Health Center - Auburn Gresham, Chicago
- Mile Square Health Center - Englewood, Chicago
- 他1件
被験者募集中第2相
全年齢 · 全性別 · 2026/07/10更新 · NCT07332741Better Lifestyle Counseling for African American Women During Pregnancy
- University of Illinois at Chicago, Chicago
- University of Illinois at Chicago, Chicago
被験者募集中
18歳〜40歳 · 女性 · 2026/07/09更新 · NCT05234125People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- Northwestern Memorial Hospital, Chicago
被験者募集中観察研究
18歳〜70歳 · 全性別 · 2026/03/17更新 · NCT07207148Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- University of Chicago, Chicago
被験者募集中第3相
18歳〜75歳 · 全性別 · 2025/11/14更新 · NCT06499857ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。